Other OTC - Delayed Quote USD

Black Bird Biotech, Inc. (BBBT)

0.0002 0.0000 (0.00%)
At close: April 18 at 3:48 PM EDT
Loading Chart for BBBT
DELL
  • Previous Close 0.0002
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0002
  • 52 Week Range 0.0000 - 0.0007
  • Volume 21,922,051
  • Avg. Volume 9,901,059
  • Market Cap (intraday) 267,814
  • Beta (5Y Monthly) 2.74
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date May 6, 2024 - May 10, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program. The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021. Black Bird Biotech, Inc. is based in Argyle, Texas.

www.blackbirdbiotech.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BBBT

Performance Overview: BBBT

Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BBBT
50.00%
S&P 500
5.06%

1-Year Return

BBBT
66.67%
S&P 500
20.71%

3-Year Return

BBBT
99.46%
S&P 500
19.73%

5-Year Return

BBBT
98.62%
S&P 500
72.77%

Compare To: BBBT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BBBT

Valuation Measures

As of 4/19/2024
  • Market Cap

    267.81k

  • Enterprise Value

    1.01M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.24

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    27.81

  • Enterprise Value/EBITDA

    -39.60

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -147.15%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    36.32k

  • Net Income Avi to Common (ttm)

    -836.13k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.73k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    146.01k

People Also Watch